Merav Ben-Yehoyada

TL;DR: In this paper, the authors analyzed the humoral response following full vaccination with the BNT162b2 (Pfizer-BioNTech) in 136 kidney transplant recipients, and compared it to 25 controls.

TL;DR: In this paper, the authors evaluated vaccine immunogenicity and safety in a special population, namely, liver transplant recipients, and found that fewer than half of the recipients developed sufficient levels of antibodies against the virus, and in those who were positive, average antibody levels were 2x less compared to healthy controls.

TL;DR: In this paper, the serologic response to BNT162b2 (Pfizer-BioNTech) vaccine in a cohort of 19 kidney transplant recipients, vaccinated prior to transplant, compare to 109 recipients vaccinated after transplantation, and to 39 healthcare workers, by determining the level of anti-spike antibodies after transplant.

TL;DR: Germline mutations in POLD1 and POLE were found to be relatively frequent in Jewish cohorts, and Phenotype of mutation carriers was notable for age under 50 at diagnosis, a propensity toward left-sided colorectal cancer, and extracolonic tumors.

TL;DR: In this article , the authors evaluated the immunogenic effect of a third-dose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in immunosuppressed patients.